RETATRUDO 32.5mg Retatrutide Prefilled Pen
Important Information: Please read the instruction completely before use.
Composition:
Retatrutide lyophilized powder USP
32.5mg/cartridge(Dual Chamber)
Concentration of 25mg
Indication:
Adult type 2 diabetes.
Weight management for obese or overweight patients (usually accompanied by dietary andexercise interventions).
Example Dose:
| 8 click | 2mg |
| 16 click | 4mg |
| 32 click | 8mg |
Dosage and Administration:
Dosage form: Injection (usually pre filled pen).Recommended dose: The initial dose is usually low, and then gradually increases based on thepatient's tolerance and treatment effectiveness. The specific dosage needs to be determined bythe doctor based on the patient's condition.Usage: Subcutaneous injection, usually once a week, can be injected into the abdomen, thigh,or upper arm.
Contraindication:
It is contraindicated for individuals allergic to Retarutide or its components.Individuals with a history of medullary thyroid carcinoma (MTC) or family history areprohibited from using it.Patients with Multiple Endocrine Adenoma Syndrome Type2(MEN 2) are contraindicated.
Adverse Reactions:
Common adverse reactions include:
Gastrointestinal reactions: nausea, vomiting, diarrhea, constipation, etc.Injection site reaction: redness, swelling, pain, or itching,Other: Hypoglycemia (when used in combination with other hypoglycemic drugs), decreasedappetite, etc.
Matters Needing Attention:
Hypoglycemic risk: When used in combination with other hypoglycemic drugs such as insulinor sulfonylurea, it may increase the risk of hypoglycemia.Pancreatitis: If severe abdominal pain occurs, seek medical attention immediately.Thyroid tumors: Monitor thyroid related symptoms such as neck lumps, swallowing difficulties,or hoarseness
Pregnancy and lactation: The safety of Retatrutide for pregnant and lactating women is not yetclear, and it is necessary to consult a doctor before use.
Drug Interactions:When used in combination with other hypoglycemic drugs, the dosage needs to be adjusted.May delay gastric emptying and affect the absorption of oral medication.
Storage:
Prior to use, the shelf life is 2 years stored at 2-8C/36-46"F.
After first opening: 4 wecks stored at2-8C. 36-46F or stored for up to3 wecks at roomtemperature not more than 25 C(77"F).
Protect from direct sunlight and do not freeze.
Keep out of the reach and sight of children.